Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
autologous hematopoietic stem cells (1 trial)
cytarabine (cytosar-u) (1 trial)
mercaptopurine (purinethol) (1 trial)
Leukemia (Phase 3)
Myelodysplastic-Myeloproliferative Diseases (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Preleukemia (Phase 3)
Trials (1 total)
Trial APIs (4 total)